Gafchromic EBT3 film provides equivalent dosimetric performance to EBT-XD film for stereotactic radiosurgery dosimetry.

Audit Dosimetry EBT-XD EBT3 Film Radiochromic film Stereotactic radiosurgery

Journal

Physical and engineering sciences in medicine
ISSN: 2662-4737
Titre abrégé: Phys Eng Sci Med
Pays: Switzerland
ID NLM: 101760671

Informations de publication

Date de publication:
13 May 2024
Historique:
received: 14 08 2023
accepted: 18 04 2024
medline: 13 5 2024
pubmed: 13 5 2024
entrez: 13 5 2024
Statut: aheadofprint

Résumé

The accurate assessment of film results is highly dependent on the methodology and techniques used to process film. This study aims to compare the performance of EBT3 and EBT-XD film for SRS dosimetry using two different film processing methods. Experiments were performed in a solid water slab and an anthropomorphic head phantom. For each experiment, the net optical density of the film was calculated using two different methods; taking the background (initial) optical density from 1) an unirradiated film from the same film lot as the irradiated film (stock to stock (S-S) method), and 2) a scan of the same piece of film taken prior to irradiation (film to film (F-F) method). EBT3 and EBT-XD performed similarly across the suite of experiments when using the green channel only or with triple channel RGB dosimetry. The dosimetric performance of EBT-XD was improved across all colour channels by using an F-F method, particularly for the blue channel. In contrast, EBT3 performed similarly well regardless of the net optical density method used. Across 21 SRS treatment plans, the average per-pixel agreement between EBT3 and EBT-XD films, normalised to the 20 Gy prescription dose, was within 2% and 4% for the non-target (2-10 Gy) and target (> 10 Gy) regions, respectively, when using the F-F method. At doses relevant to SRS, EBT3 provides comparable dosimetric performance to EBT-XD. In addition, an S-S dosimetry method is suitable for EBT3 while an F-F method should be adopted if using EBT-XD.

Identifiants

pubmed: 38739345
doi: 10.1007/s13246-024-01430-z
pii: 10.1007/s13246-024-01430-z
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. Crown.

Références

Kann BH, Park HS, Johnson SB, Chiang VL, Yu JB (2017) Radiosurgery for brain metastases: changing practice patterns and disparities in the United States. J Natl Compr Cancer Netw 15:1494–1502. https://doi.org/10.6004/jnccn.2017.7003
doi: 10.6004/jnccn.2017.7003
Pudsey L, Haworth A, White P, Moutrie Z, Jonker B, Foote M, Poder J (2022) Current status of intra-cranial stereotactic radiotherapy and stereotactic radiosurgery in Australia and New Zealand: key considerations from a workshop and surveys. Phys Eng Sci Med 45:251–259. https://doi.org/10.1007/s13246-022-01108-4
doi: 10.1007/s13246-022-01108-4 pubmed: 35113342 pmcid: 8901507
Palmer AL, Dimitriadis A, Nisbet A, Clark CH (2015) Evaluation of Gafchromic EBT-XD film, with comparison to EBT3 film, and application in high dose radiotherapy verification. Phys Med Biol 60:8741–8752. https://doi.org/10.1088/0031-9155/60/22/8741
doi: 10.1088/0031-9155/60/22/8741 pubmed: 26512917
Grams MP, Gustafson JM, Long KM, de los Santos LE (2015) Technical note: initial characterization of the new EBT-XD gafchromic film. Med Phys 42:5782–5786. https://doi.org/10.1118/1.4930058
doi: 10.1118/1.4930058 pubmed: 26429252
Khachonkham S, Dreindl R, Heilemann G, Lechner W, Fuchs H, Palmans H, Georg D, Kuess P (2018) Characteristic of EBT-XD and EBT3 radiochromic film dosimetry for photon and proton beams. Phys Med Biol 63:065007. https://doi.org/10.1088/1361-6560/aab1ee
doi: 10.1088/1361-6560/aab1ee pubmed: 29474189
Miura H, Ozawa S, Hosono F, Sumida N, Okazue T, Yamada K, Nagata Y (2016) Gafchromic EBT-XD film: dosimetry characterization in high-dose, volumetric-modulated arc therapy. J Appl Clin Med Phys 17:312–322. https://doi.org/10.1120/jacmp.v17i6.6281
doi: 10.1120/jacmp.v17i6.6281 pubmed: 27929504 pmcid: 5690510
Santos T, Ventura T, Capela M, Mateus J, do Carmo lopes M (2021) A protocol for absolute dose verification of SBRT/SRS treatment plans using gafchromic EBT-XD films. Phys Med 82:150–157. https://doi.org/10.1016/j.ejmp.2021.01.082
doi: 10.1016/j.ejmp.2021.01.082 pubmed: 33618154
Niroomand-Rad A, Chiu-Tsao S-T, Grams MP, Lewis DF, Soares CG, Van Battum LJ, Das IJ, Trichter S, Kissick MW, Massillon-JL G, Alvarez PE, Chan MF (2020) Report of AAPM task group 235 radiochromic film dosimetry: an update to TG-55. Med Phys 47:5986–6025. https://doi.org/10.1002/mp.14497
doi: 10.1002/mp.14497 pubmed: 32990328
Palmer AL, Bradley DA, Nisbet A (2015) Evaluation and mitigation of potential errors in radiochromic film dosimetry due to film curvature at scanning. J Appl Clin Med Phys 16:5141. https://doi.org/10.1120/jacmp.v16i2.5141
doi: 10.1120/jacmp.v16i2.5141 pubmed: 26103181
Marroquin EY, Herrera Gonzalez JA, Camacho Lopez MA, Barajas JE, Garcia-Garduno OA (2016) Evaluation of the uncertainty in the EBT3 film dosimetry systems utilizing net optical density. J Appl Clin Med Phys 17(5):466–481. https://doi.org/10.1120/jacmp.v17i5.6262
doi: 10.1120/jacmp.v17i5.6262 pubmed: 27685125 pmcid: 5874103
Shaw M, Lye J, Alves A, Keehan S, Lehmann J, Hanlon M, Kenny J, Baines J, Porumb C, Geso M, Brown R (2021) Characterisation of a synthetic diamond detector for end-to-end dosimetry in stereotactic body radiotherapy and radiosurgery. Phys Imaging Radiat Oncol 20:40–45. https://doi.org/10.1016/j.phro.2021.10.002
doi: 10.1016/j.phro.2021.10.002 pubmed: 34722939 pmcid: 8536779

Auteurs

Lloyd Smyth (L)

Australian Radiation Protection And Nuclear Safety Agency, Australian Clinical Dosimetry Service, Yallambie, VIC, Australia.

Andrew Alves (A)

Australian Radiation Protection And Nuclear Safety Agency, Australian Clinical Dosimetry Service, Yallambie, VIC, Australia.

Katherine Collins (K)

Australian Radiation Protection And Nuclear Safety Agency, Australian Clinical Dosimetry Service, Yallambie, VIC, Australia.

Sabeena Beveridge (S)

Australian Radiation Protection And Nuclear Safety Agency, Australian Clinical Dosimetry Service, Yallambie, VIC, Australia. sabeena.beveridge@arpansa.gov.au.

Classifications MeSH